UniProt ID | SH2B1_HUMAN | |
---|---|---|
UniProt AC | Q9NRF2 | |
Protein Name | SH2B adapter protein 1 | |
Gene Name | SH2B1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 756 | |
Subcellular Localization | Cytoplasm. Membrane . Nucleus. Shuttles between the nucleus and the cytoplasm.. | |
Protein Description | Adapter protein for several members of the tyrosine kinase receptor family. Involved in multiple signaling pathways mediated by Janus kinase (JAK) and receptor tyrosine kinases, including the receptors of insulin (INS), insulin-like growth factor I (IGF1), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs). In growth hormone (GH) signaling, autophosphorylated ('Tyr-813') JAK2 recruits SH2B1, which in turn is phosphorylated by JAK2 on tyrosine residues. These phosphotyrosines form potential binding sites for other signaling proteins. GH also promotes serine/threonine phosphorylation of SH2B1 and these phosphorylated residues may serve to recruit other proteins to the GHR-JAK2-SH2B1 complexes, such as RAC1. In leptin (LEP) signaling, binds to and potentiates the activation of JAK2 by globally enhancing downstream pathways. In response to leptin, binds simultaneously to both, JAK2 and IRS1 or IRS2, thus mediating formation of a complex of JAK2, SH2B1 and IRS1 or IRS2. Mediates tyrosine phosphorylation of IRS1 and IRS2, resulting in activation of the PI 3-kinase pathway. Acts as positive regulator of NGF-mediated activation of the Akt/Forkhead pathway; prolongs NGF-induced phosphorylation of AKT1 on 'Ser-473' and AKT1 enzymatic activity. Enhances the kinase activity of the cytokine receptor-associated tyrosine kinase JAK2 and of other receptor tyrosine kinases, such as FGFR3 and NTRK1. For JAK2, the mechanism seems to involve dimerization of both, SH2B1 and JAK2. Enhances RET phosphorylation and kinase activity. Isoforms seem to be differentially involved in IGF-I and PDGF-induced mitogenesis (By similarity).. | |
Protein Sequence | MNGAPSPEDGASPSSPPLPPPPPPSWREFCESHARAAALDFARRFRLYLASHPQYAGPGAEAAFSRRFAELFLQHFEAEVARASGSLSPPILAPLSPGAEISPHDLSLESCRVGGPLAVLGPSRSSEDLAGPLPSSVSSSSTTSSKPKLKKRFSLRSVGRSVRGSVRGILQWRGTVDPPSSAGPLETSSGPPVLGGNSNSNSSGGAGTVGRGLVSDGTSPGERWTHRFERLRLSRGGGALKDGAGMVQREELLSFMGAEEAAPDPAGVGRGGGVAGPPSGGGGQPQWQKCRLLLRSEGEGGGGSRLEFFVPPKASRPRLSIPCSSITDVRTTTALEMPDRENTFVVKVEGPSEYIMETVDAQHVKAWVSDIQECLSPGPCPATSPRPMTLPLAPGTSFLTRENTDSLELSCLNHSESLPSQDLLLGPSESNDRLSQGAYGGLSDRPSASISPSSASIAASHFDSMELLPPELPPRIPIEEGPPTGTVHPLSAPYPPLDTPETATGSFLFQGEPEGGEGDQPLSGYPWFHGMLSRLKAAQLVLTGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRLSLNEEGQCRVQHLWFQSIFDMLEHFRVHPIPLESGGSSDVVLVSYVPSSQRQQEPTTSHDPPQPPEPPSWTDPPQPGAEEASRAPEVAAAAAAAAKERQEKEKAGGGGVPEELVPVVELVPVVELEEAIAPGSEAQGAGSGGDAGVPPMVQLQQSPLGGDGEEGGHPRAINNQYSFV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | LPPPPPPSWREFCES CCCCCCCCHHHHHHH | 44.53 | 26091039 | |
48 | Phosphorylation | FARRFRLYLASHPQY HHHHHHHHHHHCCCC | 8.93 | - | |
51 | Phosphorylation | RFRLYLASHPQYAGP HHHHHHHHCCCCCCC | 32.86 | 19060867 | |
55 | Phosphorylation | YLASHPQYAGPGAEA HHHHCCCCCCCCHHH | 20.27 | 21253578 | |
65 | Phosphorylation | PGAEAAFSRRFAELF CCHHHHHHHHHHHHH | 20.16 | - | |
84 | Phosphorylation | EAEVARASGSLSPPI HHHHHHHCCCCCCCE | 24.30 | 21712546 | |
86 | Phosphorylation | EVARASGSLSPPILA HHHHHCCCCCCCEEE | 24.15 | 28102081 | |
88 | Phosphorylation | ARASGSLSPPILAPL HHHCCCCCCCEEECC | 30.26 | 22617229 | |
96 | Phosphorylation | PPILAPLSPGAEISP CCEEECCCCCCCCCC | 21.89 | 26055452 | |
102 | Phosphorylation | LSPGAEISPHDLSLE CCCCCCCCCCCCCCC | 14.00 | 30206219 | |
107 | Phosphorylation | EISPHDLSLESCRVG CCCCCCCCCCCCCCC | 35.83 | 28450419 | |
110 | Phosphorylation | PHDLSLESCRVGGPL CCCCCCCCCCCCCCE | 16.71 | 28450419 | |
123 | Phosphorylation | PLAVLGPSRSSEDLA CEEEECCCCCCCCCC | 42.89 | 23927012 | |
125 | Phosphorylation | AVLGPSRSSEDLAGP EEECCCCCCCCCCCC | 42.28 | 23401153 | |
126 | Phosphorylation | VLGPSRSSEDLAGPL EECCCCCCCCCCCCC | 33.74 | 30266825 | |
135 | Phosphorylation | DLAGPLPSSVSSSST CCCCCCCCCCCCCCC | 51.56 | 23927012 | |
136 | Phosphorylation | LAGPLPSSVSSSSTT CCCCCCCCCCCCCCC | 24.87 | 23927012 | |
138 | Phosphorylation | GPLPSSVSSSSTTSS CCCCCCCCCCCCCCC | 26.84 | 23927012 | |
139 | Phosphorylation | PLPSSVSSSSTTSSK CCCCCCCCCCCCCCC | 26.59 | 23927012 | |
140 | Phosphorylation | LPSSVSSSSTTSSKP CCCCCCCCCCCCCCC | 24.97 | 23927012 | |
141 | Phosphorylation | PSSVSSSSTTSSKPK CCCCCCCCCCCCCCC | 37.34 | 23927012 | |
142 | Phosphorylation | SSVSSSSTTSSKPKL CCCCCCCCCCCCCCH | 32.42 | 23927012 | |
143 | Phosphorylation | SVSSSSTTSSKPKLK CCCCCCCCCCCCCHH | 32.71 | 23927012 | |
144 | Phosphorylation | VSSSSTTSSKPKLKK CCCCCCCCCCCCHHH | 36.13 | 23927012 | |
145 | Phosphorylation | SSSSTTSSKPKLKKR CCCCCCCCCCCHHHC | 51.38 | 23403867 | |
154 | Phosphorylation | PKLKKRFSLRSVGRS CCHHHCEEEHHHCCC | 27.23 | 30576142 | |
157 | Phosphorylation | KKRFSLRSVGRSVRG HHCEEEHHHCCCHHH | 33.93 | 30576142 | |
161 | Phosphorylation | SLRSVGRSVRGSVRG EEHHHCCCHHHHHHH | 15.38 | 21878491 | |
165 | Phosphorylation | VGRSVRGSVRGILQW HCCCHHHHHHHHEEE | 9.70 | 21878491 | |
189 | Phosphorylation | AGPLETSSGPPVLGG CCCCCCCCCCCCCCC | 63.84 | 28555341 | |
211 | Methylation | GGAGTVGRGLVSDGT CCCCCCCCCCCCCCC | 30.82 | 115916833 | |
215 | Phosphorylation | TVGRGLVSDGTSPGE CCCCCCCCCCCCCCC | 35.05 | 27251275 | |
218 | Phosphorylation | RGLVSDGTSPGERWT CCCCCCCCCCCCHHC | 36.42 | 29255136 | |
219 | Phosphorylation | GLVSDGTSPGERWTH CCCCCCCCCCCHHCH | 36.12 | 29255136 | |
235 | Methylation | FERLRLSRGGGALKD HHHHHCCCCCCCCCC | 52.98 | 58859443 | |
270 | Methylation | PDPAGVGRGGGVAGP CCCCCCCCCCCCCCC | 37.87 | 24129315 | |
279 | Phosphorylation | GGVAGPPSGGGGQPQ CCCCCCCCCCCCCCH | 53.88 | 28555341 | |
289 | Ubiquitination | GGQPQWQKCRLLLRS CCCCHHHCCEEEEEC | 20.54 | - | |
296 | Phosphorylation | KCRLLLRSEGEGGGG CCEEEEECCCCCCCC | 50.34 | 28555341 | |
320 | Phosphorylation | KASRPRLSIPCSSIT CCCCCCEECCCCCCC | 26.26 | 24275569 | |
324 | Phosphorylation | PRLSIPCSSITDVRT CCEECCCCCCCCCEE | 21.30 | 28348404 | |
325 | Phosphorylation | RLSIPCSSITDVRTT CEECCCCCCCCCEEC | 35.90 | 28857561 | |
327 | Phosphorylation | SIPCSSITDVRTTTA ECCCCCCCCCEECEE | 30.32 | 28348404 | |
352 | Phosphorylation | VVKVEGPSEYIMETV EEEEECCCCCEEEEC | 54.62 | 29116813 | |
354 | Phosphorylation | KVEGPSEYIMETVDA EEECCCCCEEEECCH | 15.20 | 27642862 | |
369 | Phosphorylation | QHVKAWVSDIQECLS HHHHHHHHHHHHHCC | 20.49 | 28102081 | |
376 | Phosphorylation | SDIQECLSPGPCPAT HHHHHHCCCCCCCCC | 39.20 | 29978859 | |
383 | Phosphorylation | SPGPCPATSPRPMTL CCCCCCCCCCCCCCC | 25.14 | 29978859 | |
384 | Phosphorylation | PGPCPATSPRPMTLP CCCCCCCCCCCCCCC | 22.48 | 29978859 | |
389 | Phosphorylation | ATSPRPMTLPLAPGT CCCCCCCCCCCCCCC | 28.10 | 26074081 | |
396 | Phosphorylation | TLPLAPGTSFLTREN CCCCCCCCCEECCCC | 18.42 | 26074081 | |
397 | Phosphorylation | LPLAPGTSFLTRENT CCCCCCCCEECCCCC | 24.95 | 26074081 | |
400 | Phosphorylation | APGTSFLTRENTDSL CCCCCEECCCCCCCE | 33.65 | 26074081 | |
404 | Phosphorylation | SFLTRENTDSLELSC CEECCCCCCCEEEEC | 23.39 | 28857561 | |
406 | Phosphorylation | LTRENTDSLELSCLN ECCCCCCCEEEECCC | 23.00 | 28857561 | |
410 | Phosphorylation | NTDSLELSCLNHSES CCCCEEEECCCCCCC | 13.74 | 28857561 | |
415 | Phosphorylation | ELSCLNHSESLPSQD EEECCCCCCCCCCCC | 28.01 | 28857561 | |
417 | Phosphorylation | SCLNHSESLPSQDLL ECCCCCCCCCCCCEE | 48.90 | 28857561 | |
420 | Phosphorylation | NHSESLPSQDLLLGP CCCCCCCCCCEECCC | 41.44 | - | |
439 | Phosphorylation | DRLSQGAYGGLSDRP CCCCCCCCCCCCCCC | 20.67 | 25884760 | |
494 | Phosphorylation | VHPLSAPYPPLDTPE CCCCCCCCCCCCCCC | 19.73 | 12551917 | |
580 | Phosphorylation | KAKHLRLSLNEEGQC CEEEEEEECCCCCCH | 23.79 | 26657352 | |
624 | Phosphorylation | SDVVLVSYVPSSQRQ CCEEEEEECCCCCCC | 14.65 | 19534553 | |
649 (in isoform 3) | Phosphorylation | - | 15.59 | 22210691 | |
678 (in isoform 3) | Phosphorylation | - | 68.17 | 22210691 | |
753 | Phosphorylation | PRAINNQYSFV---- CCCCCCCCCCC---- | 13.24 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
96 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
96 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
161 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
165 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
439 | Y | Phosphorylation | Kinase | JAK1 | P23458 | Uniprot |
439 | Y | Phosphorylation | Kinase | JAK2 | O60674 | Uniprot |
439 | Y | Phosphorylation | Kinase | PDGFR-FAMILY | - | GPS |
439 | Y | Phosphorylation | Kinase | PDGFR | - | Uniprot |
494 | Y | Phosphorylation | Kinase | JAK1 | P23458 | Uniprot |
494 | Y | Phosphorylation | Kinase | JAK2 | O60674 | Uniprot |
753 | Y | Phosphorylation | Kinase | TRKA | P04629 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SH2B1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
145 | Phosphorylation | 148 (3) | T ⇒ A;S | rs7498665 |
| 25673412 19079261 23563607 19079260 |
154 | Phosphorylation | 148 (6) | T ⇒ A;S | rs7498665 |
| 25673412 19079261 23563607 19079260 |
157 | Phosphorylation | 148 (9) | T ⇒ A;S | rs7498665 |
| 25673412 19079261 23563607 19079260 |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FGFR3_HUMAN | FGFR3 | physical | 11827956 | |
NTRK1_HUMAN | NTRK1 | physical | 9856458 | |
GRB2_HUMAN | GRB2 | physical | 9856458 | |
JAK2_HUMAN | JAK2 | physical | 9343427 | |
JAK2_HUMAN | JAK2 | physical | 12370803 | |
INSR_HUMAN | INSR | physical | 10594240 | |
JAK2_HUMAN | JAK2 | physical | 17565041 | |
BRCA1_HUMAN | BRCA1 | physical | 17565041 | |
SH2B1_HUMAN | SH2B1 | physical | 15767667 | |
SH2B2_HUMAN | SH2B2 | physical | 15767667 | |
JAK2_HUMAN | JAK2 | physical | 15767667 | |
INSR_HUMAN | INSR | physical | 15767667 | |
IGF1R_HUMAN | IGF1R | physical | 15767667 | |
CSAD_HUMAN | CSAD | physical | 25814554 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-96, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-96, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-624, AND MASSSPECTROMETRY. |